Registry of Patients With Hypophosphatasia
Study Identifier:
ALX-HPP-501
ClinicalTrials.gov Identifier:
EudraCT Identifier:
N/A
Sponsor:
Alexion Pharmaceuticals, Inc.
Study Contact Information:
N/A
Recruiting
Study Details
Medical Condition
- Unmapped
Study Drug
Date
Apr 2017 - Dec 2031
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: N/A - N/A
Requirements Information
Sex
Female & Male
Age
N/A - N/A
Study Details
Medical Condition
- Unmapped
Study Drug
Date
Apr 2017 - Dec 2031
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: N/A - N/A years
Requirements Information
Protocol Summary
In this prospective, observational, long term registry patients of all ages with a diagnosis of hypophosphatasia (HPP) are followed at participating sites in multiple countries.
Trial Locations
Location
Status
Location
Research Site
Centennial, Colorado, United States, 80112
Status
N/A
Location
Research Site
Hartford, Connecticut, United States, 06106
Status
N/A
Location
Research Site
Tampa, Florida, United States, 33606
Status
N/A
Location
Research Site
Decatur, Georgia, United States, 30033
Status
N/A
Location
Research Site
Baltimore, Maryland, United States, 21287
Status
N/A
Location
Research Site
Boston, Massachusetts, United States, 02111
Status
N/A